에이프로젠바이오로직스
1,440KRWMarket close of 10/21 (Wed)
Down -1.50%-22KRWMarket close of 10/21 (Wed)
- Open
- 1,508
- High
- 1,509
- Low
- 1,439
- Day range
- Day range low 1,439 high 1,509, open 1,508, close 1,440, previous close 1,462
- Volume
- 8×10K shares
- 123.73 million KRW 0.70× the 20-session average
Market close of 10/21 (Wed)
Something to check
1 to check: operating loss
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsto check-58.2B KRWOperating income over the last four quarters -58.2B KRW (loss)
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
The other 3 are within the usual range
- Daily move-1.50%usual range
- Trading value0.7×usual range
- Data date10/21 (Wed)Market close
See the full check report
Quarterly results · Q1 2026
- Revenue21.6B KRW
- vs. year ago
- +28.3%
- vs. prior quarter
- +6.2%
- Operating income-13.6B KRW
- vs. year ago
- Still a loss
- vs. prior quarter
- Still a loss
- Operating margin-63.0%
- vs. year ago
- +30.4 pp
- vs. prior quarter
- +15.5 pp
Quarterly operating income trend
As of the latest official close · 2026-10-21Valuation filing date · 2026-05-14Same sector · 제약
Up +0.83%· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 삼성바이오로직스 | Close over the last 20 sessions +1.5% | Up +1.87% | 166.1B KRW |
| 셀트리온 | Close over the last 20 sessions +9.6% | Up +0.10% | 119.2B KRW |
| 지투지바이오 | Close over the last 20 sessions +27.6% | Up +13.78% | 49.8B KRW |
| 삼익제약 | Close over the last 20 sessions -20.3% | Up +2.58% | 47.2B KRW |
| 유한양행 | Close over the last 20 sessions +11.7% | Up +0.46% | 35.3B KRW |
Schedule
- Next data 10/23 (Fri) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.